<?xml version="1.0" ?>
<rss version="2.0">
<channel>
<title>MoneyShow.com - Stocks, Bonds and Commodities</title>
<link>http://www.moneyshow.com</link>
<description>MoneyShow.com- Stocks, Bonds and Commodities</description>
<copyright>Copyright 2008 MoneyShow.com Inc. All Rights Reserved.</copyright>
<managingEditor>hg@moneyshow.com</managingEditor>
<ttl>10</ttl>
<language>en-us</language>
<image>
<title>MoneyShow.com - Top Pros Top Picks</title>
<url>http://www.moneyshow.com</url>
<link>http://www.moneyshow.com/</link>
</image>
<item>
<title>Contrarian Investing</title>
<pubDate>11/6/2009</pubDate>
<description>Discover &#60;b&#62;Benj Gallander's&#60;/b&#62; contrarian take on stocks. In this session, he will focus on the methodology used at the &#60;i&#62;Contra the Head&#60;/i&#62; investment letter. It will explain some of the key components that have given the system one of the best long-term returns in North America. &#60;br&#62;</description>
<link>http://www.moneyshow.com/vidredir.asp?wid=1E99B4B5ABD64F70822A937454EC54151&#38;spn=rss&#38;scode=012485</link>
</item>
<item>
<title>Time to Buy Big Oil</title>
<pubDate>11/5/2009 1:19:00 PM</pubDate>
<description>&#60;strong&#62;Jon Markman&#60;/strong&#62;, commentator for MSN Money, calls the energy giants super bargains.</description>
<link>http://www.moneyshow.com/artredir.asp?aid=tptp110509-18151&#38;spn=rss&#38;scode=012485</link>
</item>
<item>
<title>Winning With Defense </title>
<pubDate>11/5/2009 12:21:00 PM</pubDate>
<description>&#60;strong&#62;Charles Carson&#60;/strong&#62;, editor of the &#60;em&#62;DRIP Investor&#60;/em&#62;, likes Walgreens' new prescription for success. </description>
<link>http://www.moneyshow.com/artredir.asp?aid=tptp110509-18150&#38;spn=rss&#38;scode=012485</link>
</item>
<item>
<title>Oil Sands a Top Resource Pick</title>
<pubDate>11/5/2009</pubDate>
<description>Canada expert &#60;b&#62;Gordon Pape&#60;/b&#62; thinks environmental concerns over oil from oil sands will not limit oil sands' growth and feels that this is one of the top resource picks in Canada. Tickers: SU, POT</description>
<link>http://www.moneyshow.com/vidredir.asp?wid=4623&#38;spn=rss&#38;scode=012485</link>
</item>
<item>
<title>Income in the Pipeline </title>
<pubDate>11/4/2009 11:45:00 AM</pubDate>
<description>&#60;strong&#62;Richard Lehmann&#60;/strong&#62;, editor of the &#60;em&#62;Forbes/Lehmann Income Securities Investor&#60;/em&#62;, has two energy plays for today's tough economy. </description>
<link>http://www.moneyshow.com/artredir.asp?aid=tptp110509-18139&#38;spn=rss&#38;scode=012485</link>
</item>
<item>
<title>Constructing Three Types of Income Generating Portfolios</title>
<pubDate>11/4/2009</pubDate>
<description>Investors face the most challenging macroeconomic environment since the 1930s, following the near destruction of the post WWII debt super-cycle. What's in store for global markets, traditional asset allocation, and how can investors augment future returns through strategic investing to protect portfolio wealth?&#60;br&#62;</description>
<link>http://www.moneyshow.com/vidredir.asp?wid=130DCB89A0D84B788233BDE28CCBD8F21&#38;spn=rss&#38;scode=012485</link>
</item>
<item>
<title>Choked with Red Tape</title>
<pubDate>11/4/2009</pubDate>
<description>&#60;strong&#62;Jim Trippon&#60;/strong&#62; of &#60;em&#62;China Stock Digest&#60;/em&#62; sees lots of value in two lagging Chinese stocks whose issuers have run afoul of the bureaucracy. </description>
<link>http://www.moneyshow.com/artredir.asp?aid=tptp110509-18141&#38;spn=rss&#38;scode=012485</link>
</item>
<item>
<title>Genuine Opportunity </title>
<pubDate>11/3/2009 2:40:00 PM</pubDate>
<description>&#60;strong&#62;Josh Peters&#60;/strong&#62; and &#60;strong&#62;David Manger&#60;/strong&#62; of &#60;em&#62;Morningstar DividendInvestor&#60;/em&#62; like Genuine Parts for the economies of scale and a safe payout that should keep growing. </description>
<link>http://www.moneyshow.com/artredir.asp?aid=tptp110509-18129&#38;spn=rss&#38;scode=012485</link>
</item>
<item>
<title>Calling Germany Collect </title>
<pubDate>11/3/2009 1:12:00 PM</pubDate>
<description>&#60;strong&#62;Neil George&#60;/strong&#62;, editor of &#60;em&#62;By George&#60;/em&#62; and &#60;em&#62;Stocks That Pay You&#60;/em&#62;, recommends two dominant&#0038;mdash;and generous&#0038;mdash;utilities.</description>
<link>http://www.moneyshow.com/artredir.asp?aid=tptp110509-18130&#38;spn=rss&#38;scode=012485</link>
</item>
<item>
<title>Minimally Invasive, Painless, and Efficient Clinical Diagnostics</title>
<pubDate>11/3/2009</pubDate>
<description>SensiVida Medical Technologies is a painless, efficient, biomedical diagnostic company. The company is commercializing a revolutionary digital painless allergy test system. This unique offering aims to capture a significant market share of the $1.6 billion market, growing at 7% a year. The second product is a proprietary, painless glucose monitor for diabetics.&#0038;nbsp;&#60;br&#62;&#60;br&#62;</description>
<link>http://www.moneyshow.com/vidredir.asp?wid=D66D7BFEAE4A4775B6D6C15B1D6DCE831&#38;spn=rss&#38;scode=012485</link>
</item>
</channel>
</rss>
